WATSON 409
Pill imprint WATSON 409 has been identified as Lisinopril 40 mg.
Lisinopril is used in the treatment of high blood pressure; heart failure; heart attack; diabetic kidney disease; migraine prevention (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy.
Lisinopril 40 mg is not subject to the Controlled Substances Act.
See also related documents.
Lisinopril Images
- Imprint:
-
WATSON 409
- Strength:
- 40 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
dibasic calcium phosphate
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
pregelatinized starch
corn starch
FD&C Yellow No. 5 Aluminum Lake
FD&C Yellow No. 5
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0409
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4646 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Lisinopril resources
- Lisinopril
- Lisinopril (Wolters Kluwer)
- lisinopril (Cerner Multum)
- lisinopril (Micromedex) - Includes Dosage Information
- Lisinopril (AHFS DI)
- Lisinopril (FDA)
- Lisinopril (Wolters Kluwer)
Search Again
